| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.96▲ | 3.93▲ | 3.92▲ | 3.92▲ | 3.89▲ |
| MA10 | 3.96▼ | 3.93▲ | 3.93▲ | 3.87▲ | 3.38▲ |
| MA20 | 3.95▲ | 3.95▲ | 3.97▼ | 3.84▲ | 2.98▲ |
| MA50 | 3.93▲ | 3.96▲ | 3.85▲ | 3.26▲ | 2.01▲ |
| MA100 | 3.94▲ | 3.86▲ | 3.85▲ | 2.85▲ | 2.14▲ |
| MA200 | 3.98▼ | 3.84▲ | 3.56▲ | 2.00▲ | 3.12▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.001▲ | -0.012▼ | -0.020▼ | 0.095▲ |
| RSI | 56.889▲ | 51.469▲ | 53.450▲ | 59.412▲ | 68.687▲ |
| STOCH | 47.803 | 35.938 | 26.337 | 49.000 | 85.507▲ |
| WILL %R | -27.273 | -43.750 | -64.706 | -36.000 | -9.836▲ |
| CCI | 5.645 | 112.991▲ | -12.147 | 64.470 | 112.178▲ |
| CDL | $ESPR Harami Candlestick Pattern Detected | Set Alert |
|
Sunday, November 16, 2025 04:00 PM
Fintel reports that on November 25, 2025, Piper Sandler initiated coverage of Esperion Therapeutics (NasdaqGM:ESPR) with a Overweight recommendation. As of November 17, 2025, the average one-year ...
|
|
Friday, October 17, 2025 08:53 AM
Esperion Therapeutics ESPR announced that it has nominated ESP-2001, a highly specific allosteric ATP citrate lyase (“ACLY”) inhibitor, as its new preclinical development candidate for the treatment ...
|
|
Tuesday, August 05, 2025 08:57 PM
Esperion develops and commercializes prescription medicines to lower cholesterol and reduce cardiovascular risk for patients who are unable to achieve goals on statins. The company’s two main products ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/12/25 | 3.90 | 4.035 | 3.865 | 3.95 | 2,576,589 |
| 23/12/25 | 4.02 | 4.13 | 3.87 | 3.88 | 5,186,321 |
| 22/12/25 | 3.95 | 4.10 | 3.93 | 4.04 | 6,285,664 |
| 19/12/25 | 3.78 | 4.04 | 3.78 | 3.93 | 12,480,672 |
| 18/12/25 | 3.68 | 3.815 | 3.68 | 3.80 | 4,136,066 |
| 17/12/25 | 3.74 | 3.75 | 3.63 | 3.65 | 3,037,044 |
| 16/12/25 | 3.76 | 3.81 | 3.67 | 3.71 | 5,720,719 |
| 15/12/25 | 3.89 | 3.90 | 3.71 | 3.78 | 4,529,998 |
| 12/12/25 | 4.10 | 4.13 | 3.84 | 3.85 | 5,284,383 |
| 11/12/25 | 3.84 | 4.125 | 3.80 | 4.08 | 11,440,012 |
|
|
||||
|
|
||||
|
|